Strategic Funding and Joint-Development
Business Model
SFJ Pharmaceuticals Group provides the expertise, resources, operational implementation and fully at-risk funding to accelerate the key assets in your clinical development pipeline
  1. SFJ ASSUMES 100% OF THE DEVELOPMENT & APPROVAL RISK
  2. SFJ CAN EXECUTE STUDIES AT A GLOBAL, REGIONAL, OR COUNTRY LEVEL, INCLUDING CHINA AND JAPAN
    SFJ recognizes that each of our Pharma Partners have distinct needs and requirements. We listen to our Pharma Partners to thoroughly understand their specific operational needs and then jointly construct a tailored co-development partnership.